| Previous close | 1.8500 |
| Open | 2.0600 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 27.00 |
| Expiry date | 2024-05-31 |
| Day's range | 1.6600 - 2.0600 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksPharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
AstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer (PFE) announces a multi-year, multi-phase cost reduction program.
ZacksPfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
This is the second cost-reduction program undertaken by Pfizer (PFE) in the past year. The first phase of this program is expected to save nearly $1.5 billion by 2027-end.
ZacksVaccine Stocks Rise on Growing Threat of Bird Flu Infections
The Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE) to develop bird flu vaccines over increasing fears of widespread transmission of the infection.
© 2024 Yahoo. All rights reserved.